Up a level |
Fischer-Mertens, Janina, Otte, Felix, Roderwieser, Andrea, Rosswog, Carolina, Kahlert, Yvonne, Werr, Lisa, Hellmann, Anna-Maria, Berding, Maya, Chiu, Bill, Bartenhagen, Christoph and Fischer, Matthias (2022). Telomerase-targeting compounds Imetelstat and 6-thio-dG act synergistically with chemotherapy in high-risk neuroblastoma models. Cell. Oncol., 45 (5). S. 991 - 1004. DORDRECHT: SPRINGER. ISSN 2211-3436
Lategahn, Jonas, Tumbrink, Hannah L., Schultz-Fademrecht, Carsten, Heimsoeth, Alena, Werr, Lisa ORCID: 0000-0002-3697-4136, Niggenaber, Janina, Keul, Marina, Parmaksiz, Fatma ORCID: 0009-0003-3771-7128, Baumann, Matthias, Menninger, Sascha, Zent, Eldar, Landel, Ina, Weisner, Joern, Jeyakumar, Kirujan ORCID: 0000-0002-0184-6775, Heyden, Leonie, Russ, Nicole, Mueller, Fabienne, Lorenz, Carina, Braegelmann, Johannes, Spille, Inga, Grabe, Tobias ORCID: 0000-0002-8287-1971, Mueller, Matthias P., Heuckmann, Johannes M., Klebl, Bert M., Nussbaumer, Peter, Sos, Martin L. and Rauh, Daniel (2022). Insight into Targeting Exon20 Insertion Mutations of the Epidermal Growth Factor Receptor with Wild Type-Sparing Inhibitors. J. Med. Chem., 65 (9). S. 6643 - 6656. WASHINGTON: AMER CHEMICAL SOC. ISSN 1520-4804
Meeser, Alina, Bartenhagen, Christoph, Werr, Lisa, Hellmann, Anna-Maria, Kahlert, Yvonne, Hemstedt, Nadine, Nuernberg, Peter, Altmueller, Janine, Ackermann, Sandra, Hero, Barbara, Simon, Thorsten ORCID: 0000-0002-3425-8451, Peifer, Martin ORCID: 0000-0002-5243-5503, Fischer, Matthias and Rosswog, Carolina (2022). Reliable assessment of telomere maintenance mechanisms in neuroblastoma. Cell Biosci., 12 (1). LONDON: BMC. ISSN 2045-3701
Werr, Lisa ORCID: 0000-0002-3697-4136, Plenker, Dennis, Dammert, Marcel A., Lorenz, Carina, Bragelmann, Johannes, Tumbrink, Hannah L., Klein, Sebastian, Schmitt, Anna, Buttner, Reinhard, Persigehl, Thorsten, Shokat, Kevan M., Wunderlich, F. Thomas, Schram, Alison M., Peifer, Martin ORCID: 0000-0002-5243-5503, Sos, Martin L., Reinhardt, H. Christian and Thomas, Roman K. (2022). CD74-NRG1 Fusions Are Oncogenic In Vivo and Induce Therapeutically Tractable ERBB2:ERBB3 Heterodimerization. Mol. Cancer Ther., 21 (5). S. 821 - 831. PHILADELPHIA: AMER ASSOC CANCER RESEARCH. ISSN 1538-8514